ÿþ<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <title>EASL 2009 - Poster Presentations</title> <style> body { background-color:#fbecb3; background-image:url(http://www2.kenes.com/liver-congress/PublishingImages/back.jpg); background-repeat:repeat-x; margin:0px; } h1 {font:16px/16px Trebuchet Ms, Georgia,Arial, Helvetica, sans-serif; color: #005184; font-weight:bold; } h2 {font:14px/16px Trebuchet Ms, Georgia,Arial, Helvetica, sans-serif; color:#003C68; font-weight:700; text-transform:none; } table { border-right:1px solid #e19c4f; border-left:1px solid #e19c4f; background-color:white; } td { font-family:Verdana, Arial; font-size: 12px; font-weight:normal; color: #333333; } .content { padding:10px; } </style> </head> <body> <table width="750" align="center" border="0" cellspacing="0" cellpadding="0"> <tr> <td><img src="http://www2.kenes.com/liver-congress/PublishingImages/top760.jpg" width="760" height="181" /></td> </tr> <tr> <td class="content"><h1>Poster Presentations</h1> <P><b><u>Apr 25, 2009</u></b></P><H2>ALCOHOLIC LIVER DISEASE, NAFLD AND DRUG-INDUCED LIVER DISEASE - b) CLINICAL:<br /></H2><p> <a href='Abstract854.htm'><b> HEV IGG SEROPREVALENCE IN PATIENTS WITH CHRONIC LIVER DISEASE IN SOUTHWEST ENGLAND</b></a><br> <b>R.J. Ali</b>, L. Farrington, V. Ellis, R.P. Bendall, G. Courtauld, H. Hussaini, H.R. Dalton<br> <em>Royal Cornwall Hospital, Truro, UK</em><br> </p> <p> <a href='Abstract855.htm'><b> COMPARING CLINICAL UTILITY AND PREDICTION OF IN-HOSPITAL SURVIVAL OF 3 PROGNOSTIC SCORES FOR ALCOHOLIC HEPATITIS: A MEXICAN COHORT</b></a><br> <b>J. Altamirano-Gómez</b><sup>1</sup>, L. Zapata_Irissón<sup>1,2</sup>, A. Gonzalez Angulo<sup>1</sup>, A. Ortiz-Salgado<sup>1</sup>, S. Andrade<sup>1,3</sup><br> <em><sup>1</sup>Gastroenterology Unit, <sup>2</sup>Clinical Research Department, Hospital Juárez de México, <sup>3</sup>School of Medicine, Instituto Politecnico Nacional, Mexico City, Mexico</em><br> </p> <p> <a href='Abstract856.htm'><b>IRON LOAD IN HFE MUTATED PATIENTS IS DECREASED DURING MORBID OBESITY</b></a><br> <b>R. Anty</b><sup>1,2,3</sup>, Y. Deugnier<sup>4,5,6</sup>, A. Iannelli<sup>7</sup>, E. Mariné-Barjoan<sup>1</sup>, M. Dahman<sup>7</sup>, S. Bekri<sup>8,9,10</sup>, Y. Le Marchand-Brustel<sup>2,3</sup>, P. Gual<sup>1,2,3</sup>, J. Gugenheim<sup>2,3,7</sup>, A. Tran<sup>1,2,3</sup><br> <em><sup>1</sup>Hepatology Unit, Archet 2 Hospital, <sup>2</sup>Team 8 'Hepatic Complications of Obesity', INSERM U895, <sup>3</sup>University of Nice Sophia-Antipolis, Nice, <sup>4</sup>Liver Center, Pontchaillou Hospital, <sup>5</sup>CIC INSERM 0203, <sup>6</sup>University of Medecine, Rennes, <sup>7</sup>Surgery and Liver Transplantation Department, Archet 2 Hospital, Nice, <sup>8</sup>Biochemistry Department, <sup>9</sup>Aden EA 3234, Charles Nicolle Hospital, <sup>10</sup>University of Medecine, Rouen, France</em><br> </p> <p> <a href='Abstract857.htm'><b>SOFT DRINK CONSUMPTION LINKED WITH FATTY LIVER INDEPENDENTLY BY METABOLIC SYNDROME DIAGNOSIS </b></a><br> A. Abed<sup>1</sup>, W. Nseir<sup>2</sup>, T. Ali<sup>1</sup>, S. Dabush<sup>1</sup>, M. Grosovski<sup>3</sup>, <b>N. Assy</b><sup>1,4</sup><br> <em><sup>1</sup>Liver Unit, Ziv Medical Centre, Safed, <sup>2</sup>Internal Medicine, Holly Family Hospital, Nazareth, <sup>3</sup>Ort Braude College of Engineering, Carmiel, <sup>4</sup>Technion Institute, Haifa, Israel</em><br> </p> <p> <a href='Abstract858.htm'><b>ASSOCIATION BETWEEN -55CT POLYMORPHISM OF UCP3 GENE AND NON ALCOHOLIC FATTY LIVER DISEASE</b></a><br> R. Aller<sup>1</sup>, D. De Luis<sup>2</sup>, O. Izaola<sup>2</sup>, <b>J.M. Gonzalez-Hernandez</b><sup>2</sup>, R. Conde<sup>2</sup>, T. Alvarez<sup>3</sup>, M.C. Velasco<sup>4</sup>, J.M. González<sup>1</sup><br> <em><sup>1</sup>Aparato Digestivo, Hospital Clinico Universitario de Valladolid, <sup>2</sup>Endocrinology, Instituto de Endocrinología y Nutrición, <sup>3</sup>Anatomía Patológica, Hospital Clinico Universitario, <sup>4</sup>Anatomía Patológica, Hospital Universitario Rio Hortega, Valladolid, Spain</em><br> </p> <p> <a href='Abstract859.htm'><b>PREDICTIVE FACTORS FOR PURE STEATOSIS IN ALCOHOLIC PATIENTS</b></a><br> <b>N. Barri Ova</b><sup>1,2,3</sup>, S. Naveau<sup>1,2,3</sup>, J. Thaury<sup>1</sup>, A. Balian<sup>1</sup>, B. Dauvois<sup>1,2</sup>, M. Njike<sup>1</sup>, S. Prévot<sup>2,4</sup>, H. Agostini<sup>5</sup>, G. Perlemuter<sup>1,2,3</sup><br> <em><sup>1</sup>Service d'Hépato-Gastroentérologie, Hôpital Antoine Béclère, Clamart, <sup>2</sup>Faculté de Médecine Paris-Sud, Université Paris-Sud, Kremlin Bicêtre, <sup>3</sup>INSERM, U764, Institut Fédératif de Recherche 13, <sup>4</sup>Service d'Anatomie Pathologique, <sup>5</sup>Unité de Recherche Clinique, Hopital Antoine Béclère, Clamart, France</em><br> </p> <p> <a href='Abstract860.htm'><b>IMPAIRED PRODUCTION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS “ BY LIVER AND ADIPOSE TISSUE</b> <b>IN ALCOHOLIC LIVER DISEASE</b></a><br> S. Naveau<sup>1,2,3</sup>, <b>N. Barriova</b><sup>1,2,3</sup>, L. Bouchet- Delbos<sup>2,3</sup>, M. Njiké-Nakseu<sup>1</sup>, A. Balian<sup>1</sup>, S. Maitre<sup>4</sup>, S. Prévot<sup>5</sup>, C. Vons<sup>6</sup>, I. Dagher<sup>3,6</sup>, H. Agostini<sup>7</sup>, D. Franco<sup>6</sup>, D. Emilie<sup>2,3</sup>, A.-M. Cassard-Doulcier<sup>2</sup>, G. Perlemuter<sup>1,2,3</sup><br> <em><sup>1</sup>Service d'Hépato-Gastroentérologie, Hôpital Antoine Béclère, <sup>2</sup>INSERM, U764, Institut Fédératif de Recherche 13, Clamart, <sup>3</sup>Faculté de Médecine Paris-Sud, Université Paris-Sud, Kremlin Bicêtre, <sup>4</sup>Service de Radiologie, Hôpital Beaujon Antoine Béclère, <sup>5</sup>Service d'Anatomie Pathologique, <sup>6</sup>Service de Chirurgie, <sup>7</sup>Unité de Recherche Clinique, Hôpital Antoine Béclère, Clamart, France</em><br> </p> <p> <a href='Abstract861.htm'><b>BIOPSY-PROVEN NASH TREATMENT WITH RIMONABANT: A CASE SERIES</b></a><br> <b>F. Barros</b><br> <em>Gastroenterology, Hospital Portugues de Beneficencia em Pernambuco, Recife, Brazil</em><br> </p> <p> <a href='Abstract862.htm'><b>A RANDOMIZED OPEN LABEL CLINICAL TRIAL WITH ORAL ALFA LIPOIC ACID AND VITAMIN E IN NON ALCOHOLIC FATTY LIVER DISEASE AND NON ALCOHOLIC STEATOHEPATITIS</b></a><br> <b>P.P. Basu</b><sup>1,2,3</sup>, K. Rayapudi<sup>2</sup>, T. Pacana<sup>2</sup>, S. Ramamurthy<sup>4</sup>, R. Brown Jr.<sup>3</sup><br> <em><sup>1</sup>NewYork Hospital Queens, Flushing, <sup>2</sup>North Shore University Hospital at Forest Hills, Forest Hills, <sup>3</sup>Columbia University College of Physicians and Surgeons, New York, NY, USA, <sup>4</sup>Royal Victoria Infirmary, New Castle upon Tyne, UK</em><br> </p> <p> <a href='Abstract863.htm'><b>ANTIOXIDANT SUPPLEMENTS FOR LIVER DISEASE</b></a><br> <b>G. Bjelakovic</b><sup>1,2</sup>, L.L. Gluud<sup>2</sup>, D. Nikolova<sup>2</sup>, M. Bjelakovic<sup>3</sup>, C. Gluud<sup>2</sup><br> <em><sup>1</sup>Department of Internal Medicine - Gastroenterology and Hepatology, Medical Faculty, University of Nis, Nis, Serbia, <sup>2</sup>The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, <sup>3</sup>Institute of Anatomy, Medical Faculty, University of Nis, Nis, Serbia</em><br> </p> <p> <a href='Abstract864.htm'><b>HISTOLOGICAL AND NON-INVASIVE QUANTITATION OF LIVER STEATOSIS</b></a><br> <b>J. Boursier</b><sup>1</sup>, J. Chaigneau<sup>1</sup>, V. Roullier<sup>1</sup>, L. Lainé<sup>2</sup>, S. Michalak<sup>1</sup>, I. Hubert<sup>1</sup>, N. Dib<sup>1</sup>, F. Oberti<sup>1</sup>, G. Hunault<sup>1</sup>, Y. Deugnier<sup>2</sup>, M.C. Rousselet<sup>1</sup>, C. Cavaro-Menard<sup>3</sup>, C. Aube<sup>1</sup>, P. Cales<sup>1</sup><br> <em><sup>1</sup>CHU, Angers, <sup>2</sup>CHU, Rennes, <sup>3</sup>Laboratoire LISA, Angers, France</em><br> </p> <p> <a href='Abstract865.htm'><b>ELEVATED MARKERS OF APOPTOTIC CELL DEATH INDICATING NASH IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME</b></a><br> S. Tan<sup>1</sup>, L.P. Bechmann<sup>2</sup>, S. Benson<sup>3</sup>, S. Eichner<sup>2</sup>, H. Lahner<sup>1</sup>, T. Dietz<sup>1</sup>, G. Gerken<sup>2</sup>, K. Mann<sup>1</sup>, <b>A.E. Canbay</b><sup>2</sup><br> <em><sup>1</sup>Endocrinology and Division of Laboratory Research, <sup>2</sup>Gastroenterology and Hepatology, <sup>3</sup>Institute of Medical Psychology and Behavioural Immunobiology, University Clinic of Essen, Essen, Germany</em><br> </p> <p> <a href='Abstract866.htm'><b>NAFLD PREVALENCE AND CARDIOVASCULAR RISK IN A POPULATION OF ADOLESCENTS IN SOUTHERN ITALY</b></a><br> <b>C.A. Caserta</b><sup>1</sup>, G.M. Pendino<sup>1</sup>, P. Surace<sup>1</sup>, M.T. Fiorillo<sup>1</sup>, S. Alicante<sup>1</sup>, C. Vacalebre<sup>1</sup>, F. Amato<sup>1</sup>, A. Amante<sup>1</sup>, M. Marra<sup>1</sup>, G. Gutamo<sup>1</sup>, A. Messineo<sup>1</sup>, M. Surace<sup>1</sup>, I. Polito<sup>1</sup>, R. Cotichini<sup>2</sup>, L. Ferrigno<sup>2</sup>, F. Rosmini<sup>2</sup>, A. Mele<sup>2</sup>, F. Marcucci<sup>2</sup><br> <em><sup>1</sup>Associazione Calabrese di Epatologia, Reggio di Calabria, <sup>2</sup>Epidemiologia Clinica e Linee Guida, Istituto Superiore di Sanità, Roma, Italy</em><br> </p> <p> <a href='Abstract867.htm'><b> INSULIN RESISTANCE MAY BETTER IDENTIFY FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) THAN SERUM ADIPOCYTOKINES</b></a><br> <b>A. Chwist</b><sup>1</sup>, M. Hartleb<sup>2</sup>, T. Kacperek-Hartleb<sup>2</sup>, M. Kajor<sup>3</sup>, M. Kukla<sup>4</sup>, K. {wirska-Korczala<sup>4</sup><br> <em><sup>1</sup>Department of Gastroenterology and Hepatology, <sup>2</sup>Department of Gastroenterology and Hepatology, <sup>3</sup>Department of Pathormorphology, Medical University of Silesia, Katowice, <sup>4</sup>Department of Physiology, Medical University of Silesia, Zabrze, Poland</em><br> </p> <p> <a href='Abstract868.htm'><b>CAN DISEASE PROGRESSION IN NON-ALCOHOLIC STEATOHEPATITIS BE STOPPED?</b></a><br> <b>I. Copaci</b><sup>1</sup>, E. Mindrut<sup>1</sup>, L. Micu<sup>1</sup>, M. Hortopan<sup>2</sup>, M. Voiculescu<sup>1</sup><br> <em><sup>1</sup>Center of Internal Medicine, <sup>2</sup>Department of Pathology, Fundeni Clinical Institute, Bucharest, Romania</em><br> </p> <p> <a href='Abstract869.htm'><b>INCREASED CIRCULATING TNF±, IL1, E IL 6, IN THE ABSENCE OF INCREASED INTESTINAL PERMEABILITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS</b></a><br> S. Mão de Ferro<sup>1</sup>, M. Salazar<sup>2</sup>, M. Machado<sup>3</sup>, F. Ramalho<sup>3</sup>, <b>H. Cortez-Pinto</b><sup>3</sup><br> <em><sup>1</sup>Gastroenterology, IPOLFG.EPE, Lisbon, <sup>2</sup>Gastroenterology, Hospital da Força Aérea, Lisboa, <sup>3</sup>Gastroenterology, Hospital de Santa Maria, Lisbon, Portugal</em><br> </p> <p> <a href='Abstract870.htm'><b>NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI e" 30 KG/M²</b></a><br> <b>V. de Lédinghen</b><sup>1,2</sup>, C. Fournier<sup>3</sup>, J. Foucher<sup>4</sup>, V. Miette<sup>3</sup>, J. Vergniol<sup>4</sup>, V. Rigalleau<sup>4</sup>, W. Merrouche<sup>4</sup>, L. Sandrin<sup>3</sup><br> <em><sup>1</sup>Bordeaux, Pessac, <sup>2</sup>INSERMU889, Universite Victor Segalen, Bordeaux, <sup>3</sup>Echosens, Paris, <sup>4</sup>Hopital Haut Leveque, Pessac, France</em><br> </p> <p> <a href='Abstract871.htm'><b> LONG-TERM SURVIVAL IN PATIENTS WITH NON SEVERE ALCOHOLIC HEPATITIS</b></a><br> <b>D. Degré</b><sup>1,2</sup>, A. Lemmers<sup>1,2</sup>, T. Gustot<sup>1,2</sup>, R. Maréchal<sup>1,2</sup>, S. Evrard<sup>2</sup>, M. Adler<sup>2</sup>, O. Le Moine<sup>1,2</sup>, J. Devière<sup>1,2</sup>, C. Moreno<sup>1,2</sup><br> <em><sup>1</sup>Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, <sup>2</sup>Departement of Gastroenterology Hepatopancreatology and Digestive Oncology, Erasme Hospital, Université Libre de Bruxelles, Brussel, Belgium</em><br> </p> <p> <a href='Abstract872.htm'><b>COMPARISON OF RISK FOR CORONARY HEART DISEASE IN PATIENTS WITH NAFLD, CHRONIC HEPATITIS C AND HEALTHY SUBJECTS</b></a><br> <b>S. Dragneva</b><sup>1</sup>, D. Valcheva<sup>1</sup>, A. Markova<sup>1</sup>, R. Ivanova<sup>2</sup>, D. Stanchev<sup>3</sup>, A. Alexiev<sup>3</sup>, K. Antonov<sup>3</sup>, D. Jelev<sup>3</sup>, V. Dimitrova<sup>4</sup>, L. Mateva<sup>3</sup><br> <em><sup>1</sup>Medical University of Sofia, <sup>2</sup>Clinic of Cardiology, University Hospital Alexandrovska, <sup>3</sup>Clinic of Gastroenterology, <sup>4</sup>Clinic of Clinical Pharmacology and Pharmacokinetics, University Hospital  St. I. Rilski , Sofia, Bulgaria</em><br> </p> <p> <a href='Abstract873.htm'><b>THE CHANGE IN SERUM AMINOTRANSFERASE LEVEL ACHIEVED BY WEIGHT REDUCTION PREDICTS THE IMPROVEMENT OF LIVER STEATOSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE</b></a><br> <b>E. Ishibashi</b><sup>1,2</sup>, Y. Eguchi<sup>1</sup>, T. Mizuta<sup>1</sup>, Y. Kitajima<sup>1,2</sup>, N. Oza<sup>1</sup>, S. Nakashita<sup>1,2</sup>, A. Matsunobu<sup>3</sup>, H. Takahashi<sup>1</sup>, Y. Kawaguchi<sup>1</sup>, R. Iwakiri<sup>1</sup>, I. Ozaki<sup>1</sup>, T. Eguchi<sup>2</sup>, N. Ono<sup>2</sup>, K. Fujimoto<sup>1</sup><br> <em><sup>1</sup>Internal Medicine, Saga Medical School, Saga, <sup>2</sup>Clinical Gastroenterology, Eguchi Hospital, Ogi, <sup>3</sup>Pathology and Biodefense, Saga Medical School, Saga, Japan</em><br> </p> <p> <a href='Abstract874.htm'><b>PLASMA APELIN LEVELS ARE ELEVATED IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</b></a><br> <b>C.N. Ercin</b><sup>1</sup>, T. Dogru<sup>1</sup>, S. Tapan<sup>2</sup>, Y. Karslioglu<sup>3</sup>, N. Karadurmus<sup>4</sup>, S. Kilic<sup>5</sup>, G. Kilciler<sup>1</sup>, Z. Yesilova<sup>1</sup>, A. Uygun<sup>1</sup>, M. Gulsen<sup>1</sup>, S. Bagci<sup>1</sup><br> <em><sup>1</sup>Dept of Gastroenterology, <sup>2</sup>Dept of Biochemistry, <sup>3</sup>Dept of Pathology, <sup>4</sup>Dept of Internal Medicine, <sup>5</sup>Dept of Epidemiology, Gulhane Medical School, Ankara, Turkey</em><br> </p> <p> <a href='Abstract875.htm'><b> VISCERAL FAT AND INSULIN RESISTANCE ARE INDEPENDENTLY CORRELATED TO DEGREE OF LIVER STEATOSIS AND STAGE OF FIBROSIS IN A NON-SELECTIVE COHORT OF OBESE PATIENTS</b></a><br> <b>S. Francque</b><sup>1</sup>, A. Verrijken<sup>2</sup>, I. Mertens<sup>2</sup>, G. Hubens<sup>3</sup>, E. Van Marck<sup>4</sup>, P. Pelckmans<sup>1</sup>, L. Van Gaal<sup>2</sup>, P. Michielsen<sup>1</sup><br> <em><sup>1</sup>Department of Gastroenterology Hepatology, <sup>2</sup>Department of Endocrinology, Diabetes and Metabolism, <sup>3</sup>Department of Abdominal Surgery, <sup>4</sup>Department of Pathology, University Hospital Antwerp, Edegem, Belgium</em><br> </p> <p> <a href='Abstract876.htm'><b>A COMPARATIVE STUDY BETWEEN ULTRASOUND EVALUATION, LIVER STIFFNESS MEASUREMENT AND BIOPSY FOR STAGING OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE </b></a><br> <b>S. Gaia</b><sup>1</sup>, C. Cocuzza<sup>1</sup>, E. Rolle<sup>1</sup>, E. Bugianesi<sup>1</sup>, P. Carucci<sup>1</sup>, E. Vanni<sup>1</sup>, A. Evangelista<sup>2</sup>, M. Rizzetto<sup>1</sup>, F. Brunello<sup>1</sup><br> <em><sup>1</sup>Gastrohepatology, <sup>2</sup>Epidemiology, San Giovanni Battista Hospital, Turin, Italy</em><br> </p> <p> <a href='Abstract877.htm'><b> MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CRITERIA OF PERIPHERAL BLOOD HAEMATOPOIETIC STEM CELLS AUTO-TRANSPLANTATION EFFICIENCY IN PATIENTS WITH CHRONIC ALCOHOLIC HEPATITIS</b></a><br> <b>A. Gumerova</b>, A. Kiassov, I. Gazizov, T. Yilmaz, S. Abdulkhakov, M. Titova, D. Andreeva, M. Kaligin<br> <em>Department of Normal Human Anatomy, Kazan State Medical University, Kazan, Russia</em><br> </p> <p> <a href='Abstract878.htm'><b>FIBROSIS SHOULD BE INCLUDED INTO THE NON-ALCOHOLIC STEATOHEPATITIS SCORING SYSTEM FOR BEING MORE PROGNOSTICATIVE</b></a><br> <b>F. Gunsar</b><sup>1</sup>, F. Yilmaz<sup>2</sup>, N.G. Unal<sup>1</sup>, B. Bayrakci<sup>1</sup>, Z. Karasu<sup>1</sup>, D. Nart<sup>2</sup>, G. Ersoz<sup>1</sup>, U.S. Akarca<sup>1</sup><br> <em><sup>1</sup>Department of Gastroenterology, <sup>2</sup>Department of Pathology, Ege University Medical School, Izmir, Turkey</em><br> </p> <p> <a href='Abstract879.htm'><b> SERUM TRIGLYCERIDE LEVEL AS A METABOLIC RISK FACTOR WAS INDEPENDENTLY ASSOCIATED WITH SERUM AMINOTRANSFERASE LEVEL IN NONALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH CENTRAL OBESITY</b></a><br> <b>E. Ishibashi</b><sup>1,2</sup>, Y. Eguchi<sup>1</sup>, T. Mizuta<sup>1</sup>, Y. Kitajima<sup>1,2</sup>, N. Oza<sup>1</sup>, S. Nakashita<sup>1,2</sup>, A. Matsunobu<sup>3</sup>, H. Takahashi<sup>1</sup>, Y. Kawaguchi<sup>1</sup>, I. Ozaki<sup>1</sup>, R. Iwakiri<sup>1</sup>, T. Eguchi<sup>2</sup>, N. Ono<sup>2</sup>, K. Fujimoto<sup>1</sup><br> <em><sup>1</sup>Internal Medicine, Saga Medical School, Saga, <sup>2</sup>Clinical Gastroenterology, Eguchi Hospital, Ogi, <sup>3</sup>Pathology and Biodefense, Saga Medical School, Saga, Japan</em><br> </p> <p> <a href='Abstract880.htm'><b> DETERMINATION OF SEVERE FIBROSIS AND CIRRHOSIS IN ALCOHOLIC PATIENTS BY TRANSIENT ELASTOGRAPHY: A PROSPECTIVE COMPARISON WITH LIVER BIOPSY</b></a><br> <b>F. Janssens</b><sup>1</sup>, N. de Surray<sup>2</sup>, Y. Horsmans<sup>2</sup>, H. Piessevaux<sup>2</sup>, P. de Timary<sup>3</sup>, P. Stärkel<sup>2</sup><br> <em><sup>1</sup>Gastroenterology, <sup>2</sup>Gastroenterology, <sup>3</sup>Adult Psychopathology, St. Luc University Hospital, Brussels, Belgium</em><br> </p> <p> <a href='Abstract881.htm'><b>THE CLINICAL COURSE OF ALCOHOLIC LIVER CIRRHOSIS: A DANISH POPULATION-BASED STUDY</b></a><br> <b>P. Jepsen</b><sup>1</sup>, H. Vilstrup<sup>2</sup>, P.K. Andersen<sup>3</sup>, P. Ott<sup>2</sup>, H.T. Sørensen<sup>1</sup><br> <em><sup>1</sup>Department of Clinical Epidemiology, <sup>2</sup>Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus, <sup>3</sup>Department of Biostatistics, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark</em><br> </p> <p> <a href='Abstract882.htm'><b> CYTOCHOME P450 2E1 (CYP2E1) AUTOREACTIVITY IN ALCOHOLIC LIVER DISEASE: NO EVIDENCE FOR A PATHOGENETIC ROLE</b></a><br> J. Palmer, A. Burt, C. Day, <b>D. Jones</b><br> <em>Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK</em><br> </p> <p> <a href='Abstract883.htm'><b> EFFECTS OF METFORMIN AND CARNITINE COMPLEX ON PERIPHERAL BLOOD MITOCHONDRIA COPY NUMBER IN PATIENTS WITH NAFLD</b></a><br> <b>D.W. Jun</b><sup>1</sup>, S.S. Jang<sup>2</sup>, W.K. Cho<sup>1</sup>, J.D. Cae<sup>3</sup>, B.K. Son<sup>1</sup>, S.H. Kim<sup>1</sup>, Y.J. Jo<sup>1</sup>, Y.S. Park<sup>1</sup><br> <em><sup>1</sup>Internal Medicine, Eulji Hospital, <sup>2</sup>College of Pharmacy, Chung-Ang University, <sup>3</sup>Clinical Pathology, Eulji Hospital, Seoul, South Korea</em><br> </p> <p> <a href='Abstract884.htm'><b>VISCERAL ADIPOSE TISSUE AREA AS A STRONG AND INDEPENDENT RISK FACTOR OF ELEVATED LIVER ENZYME</b></a><br> <b>D. Kim</b><sup>1</sup>, Y.J. Kim<sup>2</sup>, J.I. Yang<sup>1</sup>, J.-H. Yoon<sup>2</sup>, S.-H. Cho<sup>1</sup>, M.-W. Sung<sup>1</sup>, H.-S. Lee<sup>2</sup><br> <em><sup>1</sup>Department of Internal Medicine, Seoul National University Hospital, Gangnam Healthcare Center, <sup>2</sup>Department of Internal Medicine, Liver Research Institute, Seoul National University College, Seoul, South Korea</em><br> </p> <p> <a href='Abstract885.htm'><b> SHORT-TERM PROGNOSTIC FACTORS OF ALCOHOLIC LIVER DISEASE PRESENTED WITH SIGNIFICANT JAUNDICE: COMPARISIONS OF SERIAL MELD, DELTA-MELD, CHILD-TURCOTTE-PUGH SCORES, AND DISCRIMINANT FUNCTION</b></a><br> <b>J.D. Kim</b>, J.M. Yang, U.I. Chang, J.Y. Choi, S.H. Bae, S.K. Yoon, J.W. Jang, C.W. Kim, S.H. Cho, J.-Y. Han, Y.S. Lee<br> <em>Internal Medicine, The Catholic University of Korea, Seoul, South Korea</em><br> </p> <p> <a href='Abstract886.htm'><b> SERUM HYALURONIC ACID AS A NONINVASIVE MARKER OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS</b></a><br> <b>O. Kolesnikova</b>, I. Chupin, V. Nemtsova<br> <em>Gastroenterology, Kharkov National Medical University, Kharkov, Ukraine</em><br> </p> <p> <a href='Abstract887.htm'><b>SERUM LEVELS OF CHEMERIN AND VASPIN IN NONALCOHOLIC FATTY LIVER DISEASE</b></a><br> <b>M. Kukla</b><sup>1</sup>, K. {wirska-Korczala<sup>1</sup>, M. Hartleb<sup>2</sup>, M. Waluga<sup>2</sup>, A. Chwist<sup>2</sup>, M. Kajor<sup>3</sup>, M. CiupiDska-Kajor<sup>3</sup>, A. Berdowska<sup>4</sup>, E. Wozniak-Grygiel<sup>1</sup>, R. BuBdak<sup>1</sup><br> <em><sup>1</sup>Physiology, Medical University of Silesia in Katowice, Zabrze, <sup>2</sup>Gastroenterology, <sup>3</sup>Histopathology, Medical University of Silesia in Katowice, Katowice, <sup>4</sup>Microbiology and Biotechnology, Jan DBugosz University, Czstochowa, Poland</em><br> </p> <p> <a href='Abstract888.htm'><b>GILBERT'S SYNDROME AND HYPERBILIRUBINEMIA IN PROTEASE INHIBITOR THERAPY - AN EXTENDED HAPLOTYPE OF GENETIC VARIANTS INCREASES RISK IN INDINAVIR TREATMENT </b></a><br> <b>T. Lankisch</b><sup>1</sup>, G. Behrens<sup>2</sup>, U. Ehmer<sup>3</sup>, U. Möbius<sup>2</sup>, J. Rockstroh<sup>4</sup>, M. Wehmeier<sup>5</sup>, S. Kalthoff<sup>3</sup>, N. Freiberg<sup>3</sup>, M. Manns<sup>3</sup>, R. Schmidt<sup>2</sup>, C. Strassburg<sup>3</sup><br> <em><sup>1</sup>Gastroenterology & Hepatology, <sup>2</sup>Clinical Immunology, <sup>3</sup>Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, <sup>4</sup>General Internal Medicine I, University Hospital of Bonn, Bonn, <sup>5</sup>Clinical Chemistry, Medical School Hannover, Hannover, Germany</em><br> </p> <p> <a href='Abstract889.htm'><b>HIGH-FAT DIET AND THE RISK FOR NON-ALCOHOLIC FATTY LIVER DISEASE: A POPULATION BASED-STUDY</b></a><br> <b>S. Lobello</b><sup>1</sup>, A. Floreani<sup>2</sup>, A. Bressan<sup>2</sup>, I. Petridis<sup>3</sup>, E. Rosa Rizzotto<sup>4</sup>, O. Di Andrea<sup>5</sup>, R. Testa<sup>6</sup>, M. Marra<sup>7</sup>, L. Salmaso<sup>8</sup>, M. Chiaramonte<sup>3</sup><br> <em><sup>1</sup>ASL 16, <sup>2</sup>Dept of Surgical and Gastroenterological Sci, University of Padova, Padova, <sup>3</sup>Dept of Medicine and Public Health, University of L'Aquila, L'Aquila, <sup>4</sup>University of Padovaii, Padova, <sup>5</sup>ASL 16, Teramo, <sup>6</sup>Dept of Gerontology, Diabetology Unit, INRCA, <sup>7</sup>Dept of Gerontology, Diabetology Unit, INRCAi, Ancona, <sup>8</sup>Dept of Statistics, University of Padova, Padova, Italy</em><br> </p> <p> <a href='Abstract890.htm'><b>QUANTITATION OF STEATOSIS BY MAGNETIC RESONANCE IMAGING (MRI) AND SPECTROSCOPY (MRS) IN LIVER DISEASE: EFFECT OF HEPATIC FIBROSIS</b></a><br> <b>S. Mcpherson</b><sup>1</sup>, G. Cowin<sup>2</sup>, P. O'Rourke<sup>3</sup>, A. Volp<sup>4</sup>, L. Horsfall<sup>1</sup>, L. Burke<sup>1</sup>, J. Jonsson<sup>5</sup>, A. Clouston<sup>1</sup>, J. Fawcett<sup>6</sup>, G. Galloway<sup>2</sup>, M. Benson<sup>4</sup>, E. Powell<sup>1</sup><br> <em><sup>1</sup>Gastroenterology and Hepatology, Princess Alexandra Hospital, <sup>2</sup>Centre for Magnetic Resonance, University of Queensland, <sup>3</sup>Cancer and Population Studies Group, Queensland Institute of Medical Research, <sup>4</sup>Radiology, Princess Alexandra Hospital, <sup>5</sup>University of Queensland, <sup>6</sup>Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia</em><br> </p> <p> <a href='Abstract891.htm'><b>ENTERAL NUTRITION WITH OR WITHOUT N-ACETYLCYSTEINE IN THE TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS : A RANDOMIZED, MULTICENTER, CONTROLLED TRIAL</b></a><br> <b>C. Moreno</b><sup>1</sup>, P. Langlet<sup>2</sup>, A. Hittelet<sup>1</sup>, S. Evrard<sup>1</sup>, L. Lasser<sup>2</sup>, I. Colle<sup>3</sup>, A. Lemmers<sup>1</sup>, J. Devière<sup>1</sup>, O. Le Moine<sup>1</sup><br> <em><sup>1</sup>Department of Gastroenterology and Hepatopancreatology, Erasme Hospital, Université Libre de Bruxelles, <sup>2</sup>Department of Hepatogastroenterology, Brugmann University Hospital, Brussels, <sup>3</sup>Department of Hepatology and Gastroenterology, Ghent University Hospital, Ghent, Belgium</em><br> </p> <p> <a href='Abstract892.htm'><b>ALCOHOLIC STEATOHEPATITIS INCREASES LIVER STIFFNESS INDEPENDENT OF FIBROSIS STAGE: CRITERIA FOR NONINVASIVE FIBROSIS ASSESSMENT</b></a><br> <b>S. Mueller</b><sup>1</sup>, G. Millonig<sup>1</sup>, L. Sarovska<sup>1</sup>, S. Friedrich<sup>1</sup>, F.M. Reimann<sup>1</sup>, M. Pritsch<sup>2</sup>, S. Eisele<sup>3</sup>, F. Stickel<sup>3</sup>, T. Longerich<sup>4</sup>, P. Schirmacher<sup>4</sup>, H.K. Seitz<sup>1</sup><br> <em><sup>1</sup>Salem Medical Center, <sup>2</sup>Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany, <sup>3</sup>Clinical Pharmacology, University of Bern, Bern, Switzerland, <sup>4</sup>Dept. of Pathology, Univ. of Heidelberg, Heidelberg, Germany</em><br> </p> <p> <a href='Abstract893.htm'><b> POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</b></a><br> <b>V. Nemtsova</b>, E. Semyatichko, O. Kolesnikova<br> <em>Gastroenterology, Kharkov National Medical University, Kharkov, Ukraine</em><br> </p> <p> <a href='Abstract894.htm'><b>IS ACANTHOSIS NIGRICANS A USEFUL CLINICAL SCREENING TEST FOR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN RESOURCE POOR SETTINGS?</b></a><br> <b>M.A. Niriella</b><sup>1</sup>, A.S. Dassanayake<sup>2</sup>, K.V.U. Kalubovila<sup>1</sup>, A.P. de Silva<sup>3</sup>, A.R. Wickramasinghe<sup>4</sup>, N. Kato<sup>5</sup>, M. Makaya<sup>5</sup>, H.J. de Silva<sup>3</sup><br> <em><sup>1</sup>University Medical Unit, Colombo North Teaching Hospital, <sup>2</sup>Department of Pharmacology, <sup>3</sup>Department of Clinical Medicine, <sup>4</sup>Department of Community Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka, <sup>5</sup>International Medical Centre of Japan, Tokyo, Japan</em><br> </p> <p> <a href='Abstract895.htm'><b>RETINOL-BINDING PROTEIN 4: A PROMISING CIRCULATING MARKER OF LIVER DAMAGE IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE</b></a><br> <b>V. Nobili</b><sup>1</sup>, N. Alkhouri<sup>2</sup>, M. Manco<sup>3</sup>, S. Ottino<sup>3</sup>, R. Lopez<sup>4</sup>, A. Alisi<sup>1</sup>, A. Feldstein<sup>2</sup><br> <em><sup>1</sup>Liver Unit,  Bambino Gesù Children's Hospital and Research Institut, Rome, Italy, <sup>2</sup>Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, OH, USA, <sup>3</sup> Bambino Gesù Children's Hospital and Research Institut, Rome, Italy, <sup>4</sup>Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA</em><br> </p> <p> <a href='Abstract896.htm'><b> DYSMETABOLIC HEPATIC IRON OVERLOAD SYNDROME: ANALYSIS OF HEPCIDIN RESPONSE TO ACUTE ORAL IRON AND CHRONIC IRON OVERLOAD</b></a><br> <b>V. Paolini</b><sup>1</sup>, P. Trombini<sup>1</sup>, S. Pelucchi<sup>1</sup>, R. Mariani<sup>1</sup>, A. Salvioni<sup>1</sup>, M. Pozzi<sup>1</sup>, E. Nemeth<sup>2</sup>, T. Ganz<sup>2</sup>, A. Piperno<sup>1</sup><br> <em><sup>1</sup>Department of Clinical Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy, <sup>2</sup>Departments of Medicine and Pathology, D. Geffen School of Medicine, University of California, Los Angeles, CA, USA</em><br> </p> <p> <a href='Abstract897.htm'><b> PROSPECTIVE COMPARISON OF SEVERITY SCORES IN ALCOHOLIC HEPATITIS</b></a><br> <b>R. Parker</b><sup>1</sup>, C.A. McCune<sup>1</sup>, F. Gordon<sup>1</sup>, A. di Mambro<sup>2</sup>, H. Taylor<sup>3</sup>, P. Collins<sup>1</sup><br> <em><sup>1</sup>Department of Hepatology, Bristol Royal Infirmary, <sup>2</sup>Department of Medicine, University of Bristol, <sup>3</sup>R&D, Bristol Royal Infirmary, Bristol, UK</em><br> </p> <p> <a href='Abstract898.htm'><b>RAISED ALT IS ASSOCIATED WITH ETHNICITY IN A LARGE GENERAL POPULATION COHORT IN LONDON UK (LOLIPOP STUDY)</b></a><br> <b>J. Parkes</b><sup>1</sup>, S. Harris<sup>1</sup>, E. Lightstone<sup>2</sup>, J. Chambers<sup>3</sup>, J. Kooner<sup>3</sup>, P. Roderick<sup>1</sup><br> <em><sup>1</sup>Public Health Sciences & Medical Statistics, University of Southampton, Southampton, <sup>2</sup>Division of Medicine, Imperial College University of London, <sup>3</sup>Department of Cardiology, Ealing Hospital, London, UK</em><br> </p> <p> <a href='Abstract899.htm'><b> CANNABINOID RECEPTOR 1 EXPRESSION CORRELATES WITH ALCOHOL-INDUCED LIVER FIBROSIS: ROLE OF ACETALDEHYDE</b></a><br> <b>E. Patsenker</b><sup>1</sup>, G. Millonig<sup>2</sup>, S. Mueller<sup>2</sup>, H.K. Seitz<sup>3</sup>, F. Stickel<sup>1</sup><br> <em><sup>1</sup>Institute of Clinical Pharmacology and Visceral Research, University of Bern, Bern, Switzerland, <sup>2</sup>Center of Alcohol Research, Liver Disease and Nutrition, University of Heidelberg, <sup>3</sup>Department of Medicine, Salem Medical Center, Heidelberg, Germany</em><br> </p> <p> <a href='Abstract900.htm'><b>GLUCOCORTICOID-INDUCED LEUCINE ZIPPER: A KEY PROTEIN IN THE SENSITIZATION OF MONOCYTES TO LIPOPOLYSACCHARIDE IN ALCOHOLIC HEPATITIS</b></a><br> H. Hamdi<sup>1,2</sup>, A.-M. Cassard-Doulcier<sup>1</sup>, A. Bigorgne<sup>1,2</sup>, A. Balian<sup>3</sup>, L. Bouchet-Delbos<sup>1</sup>, M.-C. Maillot<sup>1</sup>, I. Durand-Gasselin<sup>1</sup>, S. Prévot<sup>2,4</sup>, J. Delaveaucoupet<sup>5</sup>, D. Emilie<sup>1,2,6</sup>, S. Naveau<sup>1,2,3</sup>, <b>G. Perlemuter</b><sup>1,2,3</sup><br> <em><sup>1</sup>INSERM U764, Clamart, <sup>2</sup>Faculté de Médecine Paris-Sud, Univ Paris Sud, Kremlin-Bicetre, <sup>3</sup>Hepato-Gastroentérologie, <sup>4</sup>Anatomo-Pathologie, <sup>5</sup>Radiologie, <sup>6</sup>Microbiology, AP-HP, Hôpital Antoine Béclère, Clamart, France</em><br> </p> <p> <a href='Abstract901.htm'><b>IMPROVED SURVIVAL IN PATIENTS WITH ADVANCED ALCOHOLIC HEPATITIS (AAH) WITH A COMBINED TREATMENT ASSOCIATING A NON-ABSORBABLE ANTIBIOTIC RIFAXIMIN TO CORTICOIDS PLUS URSODEOXICHOLIC ACID (UDCA)</b></a><br> <b>A. Popescu</b>, M. Voiculescu<br> <em>Internal Medicine, Fundeni Clinical Institute, Bucharest, Romania</em><br> </p> <p> <a href='Abstract902.htm'><b> SCREENING FOR LIVER ADVANCED FIBROSIS USING NON-INVASIVE BIOMARKER FIBROTEST IN GENERAL POPULATION</b></a><br> <b>T. Poynard</b><sup>1</sup>, P. Lebray<sup>1</sup>, P. Ingiliz<sup>1</sup>, A. Varaud<sup>1</sup>, B. Varsat<sup>2</sup>, Y. Ngo<sup>1</sup>, P. Nohra<sup>1</sup>, M. Munteanu<sup>3</sup>, R. Morra<sup>1</sup>, D. Messous<sup>1</sup>, F. Imbert-Bismut<sup>1</sup>, J.P. Carrau<sup>2</sup>, J. Massard<sup>1</sup>, V. Ratziu<sup>1</sup>, J.P. Giordanella<sup>2</sup><br> <em><sup>1</sup>APHP-UPMC Liver Center, <sup>2</sup>CPAM, <sup>3</sup>Biopredictive, Paris, France</em><br> </p> <p> <a href='Abstract903.htm'><b> OVERESTIMATION OF "PURE" NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AS A CAUSE OF LIVER FIBROSIS (AF) USING ALCOHOL CONSUMPTION ESTIMATED BY SELF DECLARATION (SD)</b></a><br> <b>T. Poynard</b><sup>1</sup>, P. Lebray<sup>1</sup>, A. Varaud<sup>1</sup>, P. Ingiliz<sup>1</sup>, B. Varsat<sup>2</sup>, Y. Ngo<sup>1</sup>, M. Munteanu<sup>3</sup>, D. Messous<sup>1</sup>, F. Imbert-Bismut<sup>1</sup>, J.P. Carrau<sup>2</sup>, J. Massard<sup>1</sup>, V. Ratziu<sup>1</sup>, J.P. Giordanella<sup>1</sup><br> <em><sup>1</sup>APHP-UPMC Liver Center, <sup>2</sup>CPAM, <sup>3</sup>Biopredictive, Paris, France</em><br> </p> <p> <a href='Abstract904.htm'><b>FACTORS RELATED TO LIVER STIFFNESS MEASUREMENT BY TRANSIENT ELASTOGRAPHY AMONG HEALTHY INDIVIDUALS: RESULTS FROM A PROSPECTIVE STUDY</b></a><br> <b>D. Prati</b><sup>1,2</sup>, A. Colli<sup>1</sup>, A. Berzuini<sup>1</sup>, A. Gerosa<sup>1</sup>, P. Duca<sup>3</sup>, F. Bonino<sup>2</sup><br> <em><sup>1</sup>Ospedale Alessandro Manzoni, Lecco, Lecco, <sup>2</sup>IRCCS Fondazione Policlinico, Mangiagalli e Regina Elena, <sup>3</sup>University of Milan, Milan, Italy</em><br> </p> <p> <a href='Abstract905.htm'><b>COMPARISON OF MR SPECTROSCOPY WITH MORPHOMETRIC ASSESSMENT OF LIVER BIOPSIES IN THE QUANTIFICATION FAT FRACTION IN PATIENTS WITH NAFLD</b></a><br> <b>E. Roldan-Valadez</b><sup>1</sup>, C. Rios<sup>2</sup>, R. Favila<sup>1</sup>, M. Martinez-Lopez<sup>1</sup>, M. Uribe<sup>3</sup>, N. Mendez-Sanchez<sup>4</sup><br> <em><sup>1</sup>MRI Unit, Medica Sur Clinic & Foundation, <sup>2</sup>Neurochemistry, National Institute of Neurology and Neurosurgery, <sup>3</sup>Liver Research Unit, <sup>4</sup>Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico</em><br> </p> <p> <a href='Abstract906.htm'><b>THE COG 2 GENE A2217G SINGLR NUCLEOTIDE POLYMORPHISM CONFERS SUSCEPTIBILITY TO HEPATOCYTE BALLOONING IN NASH PATIENTS</b></a><br> <b>T. Saibara</b>, T. Ochi, G. Munekage, K. Ogasawara, A. Hirose, Y. Nozaki, M. Takahashi, M. Ono, M. Morita<br> <em>Gastroenterology and Hepatology, Kochi Medical School, Nankoku, Japan</em><br> </p> <p> <a href='Abstract907.htm'><b> SERUM ADIPONECTIN LEVELS ARE PREDICTIVE OF ADVANCED HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCHOHOLIC FATTY LIVER DISEASE (NAFLD)</b></a><br> <b>S. Savvidou</b><sup>1</sup>, P. Hytiroglou<sup>2</sup>, H. Orfanou-Koumerkeridou<sup>3</sup>, A. Panderis<sup>3</sup>, P. Frantzoulis<sup>3</sup>, J. Goulis<sup>1</sup><br> <em><sup>1</sup>4rth Department of Internal Medicine, Medical School of Aristotle University, Hippocration General Hospital of Thessaloniki, <sup>2</sup>Department of Pathology, Medical School of Aristotle University of Thessaloniki, <sup>3</sup>Laboratory of Clinical Immunology, Hippocration General Hospital of Thessaloniki, Thessaloníki, Greece</em><br> </p> <p> <a href='Abstract908.htm'><b> THE EFFECT OF DIETARY INTERVENTION ON THE LONG-TERM CLINICAL OUTCOME OF NON-ALCOHOLIC FATTY LIVER DISEASE</b></a><br> R. Idilman<sup>1</sup>, <b>G. Seval</b><sup>2</sup>, K. Çinar<sup>1</sup>, D. Mizrak<sup>2</sup>, Y. Bozku_<sup>2</sup>, M. Arslan<sup>2</sup>, M. Bekta_<sup>1</sup>, E. Erden<sup>3</sup>, A. Özden<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, <sup>2</sup>Internal Medicine, <sup>3</sup>Pathology, Ankara University Faculty of Medicine, Ankara, Turkey</em><br> </p> <p> <a href='Abstract909.htm'><b> THE EVALUATION OF ASSOCIATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND SUBCLINICAL CARDIOVASCULAR DISEASE BY USING THE CORONARY ARTERY CALCIUM SCORE</b></a><br> <b>J.H. Moon</b><sup>1</sup>, S.H. Park<sup>2</sup>, H.J. Son<sup>1</sup>, K.-S. Yoo<sup>2</sup>, T. Hahn<sup>2</sup>, C.K. Park<sup>2</sup><br> <em><sup>1</sup>Center for Health Promotion, Samsung Medical Center, Seoul, <sup>2</sup>Department of Internal Medicine, Hallym University College of Medicine, Anyang-si, South Korea</em><br> </p> <p> <a href='Abstract910.htm'><b>IRON OVERLOAD IS ASSOCIATED WITH HEPATIC OXIDATIVE DAMAGE TO DNA IN NONALCOHOLIC STEATOHEPATITIS</b></a><br> <b>Y. Takei</b>, N. Fujita, H. Miyachi, J. Tanaka, T. Beppu, H. Tanaka, M. Takeo, N. Yamamoto, K. Sugimoto, M. Iwasa, Y. Kobayashi, K. Shiraki<br> <em>Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan</em><br> </p> <p> <a href='Abstract911.htm'><b> ACCURACY OF CLINICAL SCORING SYSTEMS FOR FATTY LIVER AND ADVANCED LIVER FIBROSIS IN AN UNSELECTED OVERWEIGHT AND OBESE POPULATION</b></a><br> <b>A. Verrijken</b><sup>1</sup>, S. Francque<sup>2</sup>, I. Mertens<sup>1</sup>, P. Michielsen<sup>2</sup>, L. Van Gaal<sup>1</sup><br> <em><sup>1</sup>Endocrinology, Diabetology, and Metabolism, <sup>2</sup>Gastro-enterology and Hepatology, Antwerp University Hospital - University of Antwerp, Edegem, Belgium</em><br> </p> <p> <a href='Abstract912.htm'><b> NON OBESE, NON DIABETIC PATIENTS PRESENTING WITH NON ALCOHOLIC FATTY LIVER DISEASE: AN EXPANDABLE CLINICO-PATHOLOGICAL ENTITY</b></a><br> <b>B. Vos</b><sup>1</sup>, C. Moreno<sup>1</sup>, N. Nagy<sup>2</sup>, F. Féry<sup>3</sup>, M. Cnop<sup>3</sup>, J. Devière<sup>1</sup>, M. Adler<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, Hepato-Pancreatology and Digestive Oncology, <sup>2</sup>Pathology, <sup>3</sup>Endocrinology, Erasme University Hospital, Brussel, Belgium</em><br> </p> <p> <a href='Abstract913.htm'><b>QUANTITATIVE ASSESSMENT OF ECHO INTENSITY HISTOGRAM DIFFERENCE BETWEEN LIVER AND KIDNEY IN THE PREDICTION OF HEPATIC STEATOSIS </b></a><br> <b>J.-H. Wang</b>, S.-N. Lu, C.-H. Hung, C.-H. Chen, T.-H. Hu, C.-S. Changchien, C.-M. Lee<br> <em>Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan R.O.C.</em><br> </p> <p> <a href='Abstract914.htm'><b> PREVALENCE AND RISK FACTORS OF LIVER FIBROSIS ASSOCIATED WITH METHOTREXATE IN AN ASIAN PSORIATIC POPULATION</b></a><br> <b>C.M. Yeo</b><sup>1</sup>, W.L. Yang<sup>1</sup>, C. Vu<sup>1</sup>, A. Earnest<sup>2</sup><br> <em><sup>1</sup>Department of Gastroenterology, <sup>2</sup>Clinical Research Unit, Tan Tock Seng Hospital, Singapore, Singapore</em><br> </p> <p> <a href='Abstract915.htm'><b>PLASMA LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (SRAGE) IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE </b></a><br> <b>Y. Yilmaz</b><sup>1</sup>, E. Ulukaya<sup>2</sup>, O.O. Gul<sup>3</sup>, M. Arabul<sup>4</sup>, C.B. Gul<sup>4</sup>, O. Atug<sup>1</sup>, A.Y. Oral<sup>2</sup>, E. Dolar<sup>5</sup><br> <em><sup>1</sup>Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, <sup>2</sup>Department of Biochemistry, <sup>3</sup>Department of Endocrinology, <sup>4</sup>Department of Internal Medicine, <sup>5</sup>Department of Gastroenterology, Uludag University Medical School, Bursa, Turkey</em><br> </p> <p> <a href='Abstract916.htm'><b>DIFFERENCES OF ADIPOCYTOKINE BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND CORONARY ARTERY DISEASE</b></a><br> A. Baranova<sup>1,2,3</sup>, I. Kaur<sup>1,3</sup>, N. Hossain<sup>1,3</sup>, M. Randhawa<sup>2,3</sup>, V. Chandhoke<sup>2,3</sup>, <b>Z. Younossi</b><sup>1,2,3</sup><br> <em><sup>1</sup>Center for Liver Disease, Inova Fairfax Hospital, Inova Health System, <sup>2</sup>Center for the Study of Genomics in Liver Diseases, Molecular and Microbiology Department, George Mason University, USA, <sup>3</sup>Center for Integrated Research, Inova Health System, Falls Church, VA, USA</em><br> </p> <p> <a href='Abstract917.htm'><b>INFLUENCE OF HEPATIC STEATOSIS ON THE APOB/A1 RATIO IN MALE PATIENTS WITH PREDIABETES</b></a><br> <b>J. Yun</b>, Y. Cho, J. Park, H. Kim, D. Park, C. Sohn, W. Jeon, B. Kim<br> <em>Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea</em><br> </p> <p> <a href='Abstract918.htm'><b>DISCORDANCE BETWEEN THREE SUCCESSIVE FIBROSCAN MEASUREMENTS MIRRORS THE VARIABILITY OF LIVER FIBROSIS</b></a><br> <b>S. Zelber-Sagi</b><sup>1</sup>, H. Yeshua<sup>2</sup>, S. Levit<sup>1</sup>, Y. Luria<sup>1</sup>, L. Blendis<sup>1</sup>, M. Leshno<sup>1</sup>, Z. Halpern<sup>1</sup>, R. Oren<sup>1</sup><br> <em><sup>1</sup>Tel Aviv Sourasky Medical Center, <sup>2</sup>Clalit Health Services, Tel Aviv, Israel</em><br> </p> <p> <a href='Abstract919.htm'><b>CAN SERUM LEPTIN AND ADIPONECTIN PREDICT</b> <b>LIVER INJURY IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD)? A STUDY IN THE GENERAL POPULATION</b></a><br> <b>S. Zelber-Sagi</b><sup>1</sup>, V. Ratziu<sup>2</sup>, L. Blendis<sup>1</sup>, G. Morali<sup>3</sup>, Z. Halpern<sup>1</sup>, R. Oren<sup>1</sup><br> <em><sup>1</sup>Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, <sup>2</sup>Université Pierre et Marie Curie, Hôpital Pitié Salpêtrière, Paris, France, <sup>3</sup>Shaare Zedek Medical Center, Jerusalem, Israel</em><br> </p> <p> <a href='Abstract920.htm'><b>IS FAMILIAL MEDITERRANEAN FEVER (FMF) ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)? </b></a><br> D. Rimar<sup>1</sup>, I. Rosner<sup>2</sup>, M. Rozenbaum<sup>2</sup>, <b>E. Zuckerman</b><sup>1</sup><br> <em><sup>1</sup>Liver Unit Carmel Medical Center, Technion Faculty of Medicine, <sup>2</sup>Rheumatology Department, Bnai Zion Medical Center, Haifa, Israel</em><br> </p> <a href='index.asp'>Back</a><br> <p>&nbsp;</p> <p>&nbsp;</p></td> </tr> </table> </body> </html>